Veraxa Biotech Insider Trades
NASDAQ: VRXAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 5 · $125.33K
- Sales
- 0 · $0
- Shares bought / sold
- 95.00K / 0
- Net activity
- Net buying $125,333
Veraxa Biotech insider activity
Over the last 12 months, Veraxa Biotech insiders reported 5 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $125,333 and sold $0 worth of stock, for net insider buying of $125,333. The most recent filing shows Gruninger Marc (Director) buying 9,133 shares at $1.00 on Oct 28, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put VRXA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
VRXA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 28, 2026 | Gruninger MarcDirector | Buy | 9,133 | $9.13K | Form 4 |
| Oct 27, 2026 | Gruninger MarcDirector | Buy | 867 | $849.66 | Form 4 |
| Oct 20, 2026 | Ziegler Christoph SamuelDirector | Buy | 30,000 | $32.70K | Form 4 |
| Aug 27, 2026 | Antz Christoph RudigerChief Executive Officer | Buy | 5,000 | $7.65K | Form 4 |
| Aug 27, 2026 | Baumann Oliver RolfDirector | Buy | 50,000 | $75.00K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4